Search Results: Prevention, Detection & Risk + Colorectal Cancer (8 results)
FIT Testing for Colorectal Cancer Screening in People with Lynch Syndrome
https://www.facingourrisk.org/research-clinical-trials/study/418 /fit-testing-for-colorectal-cancer-screening-in-people-with-lynch-syndrome
Prevention
Colon cancer screening study for people with Lynch syndrome
People with Lynch syndrome currently rely on regular colonoscopies to screen for colorectal cancer. Researchers are studying whether a simple stool-based test called the fecal immunochemical test (FIT) can help identify people who may need a colonoscopy while reducing the burden of frequent screening. This study will compare FIT results with colonoscopy findings in people with Lynch syndrome.
Multi-Cancer Detection Blood Tests in Adults Without Cancer: Vanguard Study
https://www.facingourrisk.org/research-clinical-trials/study/394 /multi-cancer-detection-blood-tests-in-adults-without-cancer-vanguard-study
Prevention
A study testing two multi-cancer detection blood tests in people who do not have cancer
The Vanguard Study is looking at how multi-cancer detection (MCD) blood tests could fit into cancer screening.
An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)
https://www.facingourrisk.org/research-clinical-trials/study/385 /an-early-detection-and-prevention-study-for-people-with-an-increased-risk-of-cancer-inadvance
Prevention
Study for people at risk of cancer, including previvors, survivors and family members
This study collects health information and DNA samples such as blood or saliva from participants to help researchers better understand cancer risk and early detection.
Study of a Blood Test to Look for Signs of Cancer in Higher-Risk People (CHARM2)
https://www.facingourrisk.org/research-clinical-trials/study/393 /study-of-a-blood-test-to-look-for-signs-of-cancer-in-higher-risk-people-charm2
Prevention
Blood test to find cancers earlier in high-risk people
This study is looking at how well an experimental blood test works for finding cancer earlier in people who have a higher-than-average risk of cancer because of an inherited mutation. Note: This study is only open in Canada.
Using the Drug eRapa to Prevent the Growth of Polyps in People with Familial Adenomatous Polyposis (SERENTA)
https://www.facingourrisk.org/research-clinical-trials/study/348 /study-of-the-drug-erapa-in-people-with-familial-adenomatous-polyposis-serenta
Prevention
Prevention study for people with Familial Adenomatous Polyposis (FAP) who have polyps in the colon or rectum
The purpose of this study is to find out if a medication called eRapa can help slow down the formation of polyps in people with Familial Adenomatous Polyposis (FAP).
Testing the Safety And Action of the Investigational Drug REC-4881 in People With Familial Adenomatous Polyposis (FAP) (TUPELO Study)
https://www.facingourrisk.org/research-clinical-trials/study/288 /testing-the-safety-and-action-of-the-investigational-drug-rec-4881-in-people-with-familial-adenomatous-polyposis-fap
Prevention
Prevention study for people with an APC mutation and FAP who have had colectomy surgery
This study is looking at how safe and effective the research drug REC-4881 is for treating polyps in people with Familial Adenomatous Polyposis (FAP). Participants will receive the oral drug REC-4881. A participant's dose will depend on when they join the study.
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Precancerous Polyps in Lynch Syndrome Patients (CORAL Study)
https://www.facingourrisk.org/research-clinical-trials/study/256 /early-detection-of-colorectal-cancer-for-people-with-lynch-syndrome
Prevention
People with Lynch Syndrome at risk for colon cancer
This study will colect blood and stool samples to detect colorectal cancer or precancerous polyps in people with Lynch syndrome and those diagnosed with early onset colorectal cancer, diagnosed younger than 50 years old.
A Study Comparing Two Anti-inflammatory Medications Naproxen or Aspirin for Cancer Prevention in Lynch Syndrome
https://www.facingourrisk.org/research-clinical-trials/study/281 /studying-the-use-of-naproxen-and-aspirin-for-cancer-prevention-in-people-with-lynch-syndrome
Prevention
Prevention study for people with Lynch syndrome
The trial is enrolling people with Lynch syndrome. On average, the length of this study will last one year from the start of enrollment to completion. The study will measure the effect of naproxen or aspirin on the immune cells in the gastrointestinal tract of people with Lynch syndrome. The trial will also evaluate any symptoms from the medications and any other changes of the colon and rectum.
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Colorectal Cancer
33 results
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT ID: NCT06059963 (https://clinicaltrials.gov/study/NCT06059963)
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT ID: NCT06620627 (https://clinicaltrials.gov/study/NCT06620627)
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT ID: NCT00843375 (https://clinicaltrials.gov/study/NCT00843375)
A Study of a Urine Test to Detect Colorectal Cancer
NCT ID: NCT07649057 (https://clinicaltrials.gov/study/NCT07649057)
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT ID: NCT05732623 (https://clinicaltrials.gov/study/NCT05732623)
Pilot Testing of a Colorectal Cancer Education Program
NCT ID: NCT07361614 (https://clinicaltrials.gov/study/NCT07361614)
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NCT ID: NCT05524428 (https://clinicaltrials.gov/study/NCT05524428)
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
NCT ID: NCT07095517 (https://clinicaltrials.gov/study/NCT07095517)
Guardant Shield Colorectal Cancer Screening
NCT ID: NCT07436637 (https://clinicaltrials.gov/study/NCT07436637)
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test
NCT ID: NCT06864338 (https://clinicaltrials.gov/study/NCT06864338)
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities
NCT ID: NCT07086833 (https://clinicaltrials.gov/study/NCT07086833)
Reducing Metabolic Dysregulation in Dyads
NCT ID: NCT06117241 (https://clinicaltrials.gov/study/NCT06117241)
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
NCT ID: NCT05410977 (https://clinicaltrials.gov/study/NCT05410977)
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
NCT ID: NCT06708429 (https://clinicaltrials.gov/study/NCT06708429)
Evaluation of Gixam's Efficacy Predicting the Presence of Advanced and Non-advanced Colorectal Neoplasia in a FIT Negative Population
NCT ID: NCT07623902 (https://clinicaltrials.gov/study/NCT07623902)
Positive Fit to Colonoscopy: Closing the Gap
NCT ID: NCT06763432 (https://clinicaltrials.gov/study/NCT06763432)
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT ID: NCT06342440 (https://clinicaltrials.gov/study/NCT06342440)
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
NCT ID: NCT06682650 (https://clinicaltrials.gov/study/NCT06682650)
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
NCT ID: NCT07436078 (https://clinicaltrials.gov/study/NCT07436078)
Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
NCT ID: NCT06542835 (https://clinicaltrials.gov/study/NCT06542835)
Colorectal Cancer Screening Outreach
NCT ID: NCT07345676 (https://clinicaltrials.gov/study/NCT07345676)
Collection of Samples USOPTIVAL Study
NCT ID: NCT04792684 (https://clinicaltrials.gov/study/NCT04792684)
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
NCT ID: NCT07046585 (https://clinicaltrials.gov/study/NCT07046585)
Evaluation of Gixam's Performance in a FIT Negative Population
NCT ID: NCT06612281 (https://clinicaltrials.gov/study/NCT06612281)
Shield Post-Approval Study Protocol
NCT ID: NCT06880055 (https://clinicaltrials.gov/study/NCT06880055)
CRC Screening in Unscreened Individuals 45-54
NCT ID: NCT06757192 (https://clinicaltrials.gov/study/NCT06757192)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT ID: NCT05612347 (https://clinicaltrials.gov/study/NCT05612347)
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
NCT ID: NCT07162337 (https://clinicaltrials.gov/study/NCT07162337)
Colorectal Cancer Prevention Research Study: Eat Right, Screen Right
NCT ID: NCT07393906 (https://clinicaltrials.gov/study/NCT07393906)
Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome
NCT ID: NCT07106359 (https://clinicaltrials.gov/study/NCT07106359)
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
NCT ID: NCT05447923 (https://clinicaltrials.gov/study/NCT05447923)
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT ID: NCT05694559 (https://clinicaltrials.gov/study/NCT05694559)
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT ID: NCT06745895 (https://clinicaltrials.gov/study/NCT06745895)
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.